Pleural Fluid Cytology Detects Small Cell Carcinoma Transformation in EGFR-Mutant Lung Adenocarcinoma: A Case Report.

Diagn CytopatholJul 7, 2026 (epub)
Case ReportOncology (Medical)PulmonologyOpen access

Huijun Zhou, Zhengyue He, Zhuo Wang et al.

✦ AI-curated · Sources linked

Case in brief

A 65-year-old woman with EGFR-mutant lung adenocarcinoma experienced a massive pleural effusion after initially responding to icotinib. Cytological analysis of the pleural fluid identified tumor cells indicative of small cell carcinoma, confirmed by immunohistochemistry. Molecular testing revealed the persistence of the original EGFR mutation, suggesting clonal evolution. This case highlights the utility of pleural fluid analysis in detecting histological transformation.

Diagnostic / clinical pearl

Cytological examination of pleural fluid can effectively identify small cell carcinoma transformation in patients with EGFR-mutant lung adenocarcinoma, aiding in the assessment of acquired resistance to EGFR-TKIs.

Why it matters

This case underscores the importance of integrating cytological and molecular analyses in managing lung adenocarcinoma, particularly when traditional tissue biopsies are challenging.

Source

Published in Diagn Cytopathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.